Aandeel IQMDU INTELLIGENT MEDICINE ACQUISITION CORP.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren
Inactief instrument

Andere talen Intelligent Medicine Acquisition Corp. Nasdaq

Aandelen

IQMDU

US45828D2053

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!
Gratis inschrijven
INTELLIGENT MEDICINE ACQUISITION CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
Intelligent Medicine Acquisition Corp. Announces It Will Redeem Its Public Shares
Intelligent Medicine Acquisition Corp.(NasdaqGM:IQMD) dropped from NASDAQ Composite Index
INTELLIGENT MEDICINE ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
Intelligent Medicine Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022
Intelligent Medicine Acquisition Corp. Auditor Raises 'Going Concern' Doubt
INTELLIGENT MEDICINE ACQUISITION CORP. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)
INTELLIGENT MEDICINE ACQUISITION CORP. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)
INTELLIGENT MEDICINE ACQUISITION CORP. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)
INTELLIGENT MEDICINE ACQUISITION CORP. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)
INTELLIGENT MEDICINE ACQUISITION CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
Intelligent Medicine Acquisition Corp. Announces Adjournment of Special Meeting of Stockholders
INTELLIGENT MEDICINE ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
Intelligent Medicine Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
INTELLIGENT MEDICINE ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
Intelligent Medicine Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
INTELLIGENT MEDICINE ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
Intelligent Medicine Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022
Certain Class B Common Stock of Intelligent Medicine Acquisition Corp. are subject to a Lock-Up Agreement Ending on 3-MAY-2022.
INTELLIGENT MEDICINE ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers IQMD
  4. Koers IQMDU
  5. Nieuws Intelligent Medicine Acquisition Corp.
  6. Andere talen